- Home
- TNGX vs PGNY Comparison
TNGX vs PGNY Comparison
Compare TNGX & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | PGNY |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | 680 |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TNGX | PGNY |
|---|---|---|
| Price | $12.31 | $17.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $15.00 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 2.6M | 1.5M |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.04 |
| EPS | N/A | ★ 0.65 |
| Revenue | $42,069,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | $52.63 | $10.74 |
| Revenue Next Year | N/A | $10.93 |
| P/E Ratio | ★ N/A | $27.02 |
| Revenue Growth | ★ 15.17 | 10.40 |
| 52 Week Low | $1.04 | $16.76 |
| 52 Week High | $13.60 | $28.75 |
Technical Indicators
Market Signals| Indicator | TNGX | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 29.38 |
| Support Level | $11.00 | N/A |
| Resistance Level | $13.53 | $23.73 |
| Average True Range (ATR) | 0.77 | 1.00 |
| MACD | -0.16 | -0.26 |
| Stochastic Oscillator | 54.46 | 18.92 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.